We are live on
!
Find out more
CAM
Claret Asset Management Portfolio holdings
AUM
$928M
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
-11.34%
1 Year Est. Return
+25.4%
3 Year Est. Return
+73.27%
5 Year Est. Return
+90.16%
10 Year Est. Return
–
AUM
$464M
AUM Growth
-$56.5M
(-11%)
Cap. Flow
+$11M
Cap. Flow
% of AUM
2.38%
Top 10 Holdings %
Top 10 Hldgs %
43.91%
Holding
171
New
17
Increased
57
Reduced
58
Closed
21
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Shell
SHEL
|
+$5.7M |
| 2 |
Citigroup
C
|
+$3.25M |
| 3 |
Alphabet (Google) Class A
GOOGL
|
+$2.21M |
| 4 |
PayPal
PYPL
|
+$1.63M |
| 5 |
Intuitive Surgical
ISRG
|
+$947K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
PARAP
Paramount Global 5.75% Series A Mandatory Convertible Preferred Stock
PARAP
|
+$2.01M |
| 2 |
AbbVie
ABBV
|
+$957K |
| 3 |
Brookfield
BN
|
+$658K |
| 4 |
DOO
Bombardier Recreational Products
DOO
|
+$566K |
| 5 |
Medtronic
MDT
|
+$499K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.89% |
| 2 | Healthcare | 19.29% |
| 3 | Communication Services | 12.19% |
| 4 | Financials | 11.97% |
| 5 | Consumer Staples | 8.5% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
Cameco
CCJ
$39.1B
| $398K | 0.09% |
18,933
-10,082
| -35% | -$254K |
|
102
V2X
VVX
$2.7B
| $398K | 0.09% |
11,882
| – | – |
|
103
Orion
OEC
$385M
| $390K | 0.08% |
25,127
-641
| -2% | -$10.7K |
|
104
Vanguard FTSE Developed Markets ETF
VEA
$230B
| $361K | 0.08% |
8,843
+696
| +9% | +$30.9K |
|
105
Vanguard Information Technology ETF
VGT
$141B
| $355K | 0.08% |
8,704
| – | – |
|
106
Mastercard
MA
$500B
| $340K | 0.07% |
1,078
-5
| -0.5% | -$1.72K |
|
107
Pfizer
PFE
$143B
| $339K | 0.07% |
6,469
-73
| -1% | -$3.72K |
|
108
Oracle
ORCL
$409B
| $338K | 0.07% |
4,834
-42
| -0.9% | -$3.07K |
|
109
Fortis
FTS
$28.9B
| $317K | 0.07% |
6,700
-70
| -1% | -$3.43K |
|
110
JPMorgan Chase
JPM
$937B
| $311K | 0.07% |
2,759
-552
| -17% | -$68.4K |
|
111
Cable One
CABO
$254M
| $303K | 0.07% |
235
+21
| +10% | +$26.7K |
|
112
McDonald's
MCD
$188B
| $287K | 0.06% |
1,164
+18
| +2% | +$4.43K |
|
113
iShares MSCI Brazil ETF
EWZ
$9.22B
| $286K | 0.06% |
10,449
| – | – |
|
114
Franco-Nevada
FNV
$41.4B
| $285K | 0.06% |
2,165
| – | – |
|
115
Generac Holdings
GNRC
$11.9B
| $269K | 0.06% |
1,279
+226
| +21% | +$55.6K |
|
|
TARO
116
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $261K | 0.06% |
7,226
-53
| -0.7% | -$2.02K |
|
117
iShares Global Clean Energy ETF
ICLN
$2.35B
| $257K | 0.06% |
13,500
| – | – |
|
118
Waters Corp
WAT
$36.8B
| $257K | 0.06% |
777
-40
| -5% | -$12.7K |
|
119
PepsiCo
PEP
$191B
| $248K | 0.05% |
1,488
+20
| +1% | +$3.37K |
|
|
IBDQ
120
DELISTED
iShares iBonds Dec 2025 Term Corporate ETF
IBDQ
| $244K | 0.05% |
9,875
+125
| +1% | +$3.11K |
|
121
Vanguard Total World Stock ETF
VT
$78B
| $244K | 0.05% |
2,855
| – | – |
|
122
OR Royalties Inc
OR
$5.71B
| $241K | 0.05% |
23,895
| – | – |
|
123
Procter & Gamble
PG
$338B
| $237K | 0.05% |
1,649
-5
| -0.3% | -$751 |
|
124
Nutrien
NTR
$31.7B
| $227K | 0.05% |
2,850
| – | – |
|
125
Invesco DB Agriculture Fund
DBA
$1.24B
| $222K | 0.05% |
10,870
-315
| -3% | -$6.93K |
|
Similar funds
WC
BCC
GP
ICM
TC
CFA
FPI
MHIC
Claret Asset Management's Q2 2022 Portfolio in Review
As of Q2 2022, Claret Asset Management held 171 positions worth $464M, down 11% from $520M the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Claret Asset Management's Q2 2022 filing shows 17 new, 57 increased, 58 reduced and 21 closed positions. Its largest new stake was Shell: 101,491 shares worth $5.31M. The largest sale was Paramount Global 5.75% Series A Mandatory Convertible Preferred Stock, an estimated $2.01M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Healthcare and Communication Services.
- Claret Asset Management's largest Q2 2022 buy was Shell: 101,491 shares worth $5.31M.
- Claret Asset Management added most to Alphabet (Google) Class A in Q2 2022, an estimated $2.21M increase.
- Claret Asset Management's biggest Q2 2022 reduction was AbbVie, cutting an estimated $957K.
- Claret Asset Management fully exited Paramount Global 5.75% Series A Mandatory Convertible Preferred Stock in Q2 2022, selling an estimated $2.01M.
- Claret Asset Management's ten largest holdings make up 44% of its $464M portfolio in Q2 2022.
- Claret Asset Management opened 17 new positions and closed 21 in Q2 2022.
- Claret Asset Management's portfolio value fell 11% quarter-over-quarter to $464M.
Based on Claret Asset Management's 13F filing for Q2 2022, filed 28 Jul 2022.